Rapid screening of invasive fungal infections in the hospital setting using the (1,3)-β-D-glucan assay

Maria M. Hornberger, Andrew T. Patterson, Jane H. Kerford, Brittany L. Lenz, Adnan Mir, Arturo R. Dominguez

Research output: Contribution to journalArticlepeer-review

Abstract

Disseminated candidiasis and other invasive fungal infections are a substantial cause of morbidity and mortality in immunocompromised and critically ill patients. Diagnosis of disseminated candidiasis via blood culture and skin biopsy can be unreliable and may delay treatment. (1,3)-β-D-glucan (BDG) assay is a rapid, cost-effective, noninvasive diagnostic screening tool for the dermatology hospitalist to consider.

Original languageEnglish (US)
Pages (from-to)33-34+36
JournalCutis
Volume106
Issue number1
DOIs
StatePublished - Jul 2020
Externally publishedYes

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Rapid screening of invasive fungal infections in the hospital setting using the (1,3)-β-D-glucan assay'. Together they form a unique fingerprint.

Cite this